A. González Moreno

605 total citations
40 papers, 469 citations indexed

About

A. González Moreno is a scholar working on Clinical Psychology, Behavioral Neuroscience and Psychiatry and Mental health. According to data from OpenAlex, A. González Moreno has authored 40 papers receiving a total of 469 indexed citations (citations by other indexed papers that have themselves been cited), including 12 papers in Clinical Psychology, 10 papers in Behavioral Neuroscience and 9 papers in Psychiatry and Mental health. Recurrent topics in A. González Moreno's work include Stress Responses and Cortisol (10 papers), Tryptophan and brain disorders (6 papers) and Bipolar Disorder and Treatment (5 papers). A. González Moreno is often cited by papers focused on Stress Responses and Cortisol (10 papers), Tryptophan and brain disorders (6 papers) and Bipolar Disorder and Treatment (5 papers). A. González Moreno collaborates with scholars based in Belgium, United States and Spain. A. González Moreno's co-authors include Michel Hansenne, William Pitchot, Marc Ansseau, R. von Frenckell, Patrick Papart, M. Ansseau, M. Ansseau, J. Wauthy, Jean Reggers and M Timsit-Berthier and has published in prestigious journals such as Biological Psychiatry, Psychoneuroendocrinology and Psychiatry Research.

In The Last Decade

A. González Moreno

34 papers receiving 446 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
A. González Moreno Belgium 14 147 140 131 99 97 40 469
I. Másala Italy 14 136 0.9× 94 0.7× 81 0.6× 88 0.9× 64 0.7× 31 374
M. Stamenković Austria 14 298 2.0× 131 0.9× 215 1.6× 163 1.6× 40 0.4× 30 734
Elisa Lorch United States 6 237 1.6× 102 0.7× 234 1.8× 105 1.1× 92 0.9× 8 460
Kunihiko Shioe Japan 6 107 0.7× 129 0.9× 75 0.6× 61 0.6× 61 0.6× 10 445
Stephen Morris United States 4 97 0.7× 304 2.2× 84 0.6× 111 1.1× 59 0.6× 6 604
Caitlin E. Carey United States 12 91 0.6× 59 0.4× 206 1.6× 107 1.1× 64 0.7× 19 534
Joan Massana Spain 7 129 0.9× 55 0.4× 219 1.7× 128 1.3× 191 2.0× 10 464
Rebecca Rhodes United Kingdom 8 105 0.7× 99 0.7× 309 2.4× 78 0.8× 228 2.4× 10 531
Elen Russell United Kingdom 4 64 0.4× 76 0.5× 104 0.8× 170 1.7× 45 0.5× 4 542
Dubravka Jancic United States 9 91 0.6× 75 0.5× 51 0.4× 127 1.3× 40 0.4× 11 447

Countries citing papers authored by A. González Moreno

Since Specialization
Citations

This map shows the geographic impact of A. González Moreno's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by A. González Moreno with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites A. González Moreno more than expected).

Fields of papers citing papers by A. González Moreno

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by A. González Moreno. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by A. González Moreno. The network helps show where A. González Moreno may publish in the future.

Co-authorship network of co-authors of A. González Moreno

This figure shows the co-authorship network connecting the top 25 collaborators of A. González Moreno. A scholar is included among the top collaborators of A. González Moreno based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with A. González Moreno. A. González Moreno is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Moreno, A. González, et al.. (2016). Newer substances and their effects: A case report. European Psychiatry. 33(S1). S402–S402. 1 indexed citations
2.
Moreno, A. González, et al.. (2012). Expression of the gene encoding secretor type galactoside 2 α fucosyltransferase (FUT2) and ABH antigens in patients with oral lesions. Medicina oral, patología oral y cirugía bucal. 17(1). e63–e68. 13 indexed citations
3.
Luján, M., Antonio Ferruelo, Álvaro Páez, A. González Moreno, & Antonio Berenguer. (2004). Prostate apoptosis after doxazosin treatment in the spontaneous hypertensive rat model. British Journal of Urology. 93(3). 410–414. 8 indexed citations
4.
González, Luis Llanes, Antonio Ferruelo, Álvaro Páez, et al.. (2002). The clinical utility of the prostate specific membrane antigen reverse‐transcription/polymerase chain reaction to detect circulating prostate cells: an analysis in healthy men and women. British Journal of Urology. 89(9). 882–885. 11 indexed citations
5.
Pitchot, William, Michel Hansenne, A. González Moreno, et al.. (2001). Reduced dopamine function in depressed patients is related to suicidal behavior but not its lethality. Psychoneuroendocrinology. 26(7). 689–696. 17 indexed citations
6.
Hansenne, Michel, et al.. (1997). Harm avoidance dimension of the tridimensional personality questionnaire and serotonin-1A activity in depressed patients. Biological Psychiatry. 42(10). 959–961. 37 indexed citations
7.
Pitchot, William, M. Ansseau, A. González Moreno, & Michel Hansenne. (1996). 5-HT1A receptors, alcoholism and suicidal behavior. European Neuropsychopharmacology. 6. 43–43. 1 indexed citations
8.
Hansenne, Michel, et al.. (1996). Suicidal behavior in depressive disorder: An event-related potential study. Biological Psychiatry. 40(2). 116–122. 65 indexed citations
9.
Hansenne, Michel, et al.. (1996). Growth hormone response to apomorphine in obsessive-compulsive disorder.. PubMed. 21(5). 343–5. 15 indexed citations
10.
Pitchot, William, Michel Hansenne, A. González Moreno, J. Wauthy, & M. Ansseau. (1996). [The biological basis of suicidal behavior: neuroendocrine and psychophysiological approach to the role of catecholamines].. PubMed. 95(4-5). 210–33. 5 indexed citations
11.
Hansenne, Michel, et al.. (1995). The dexamethasone suppression test in violent suicide attempters with major depression. Biological Psychiatry. 37(4). 273–274. 14 indexed citations
12.
Hansenne, Michel, et al.. (1995). Growth hormone response to clonidine in nondepressed patients with a history of suicide attempts. Biological Psychiatry. 38(3). 201–203. 6 indexed citations
13.
Hansenne, Michel, William Pitchot, A. González Moreno, et al.. (1995). Catecholaminergic function and P300 amplitude in major depressive disorder (P300 and catecholamines). Electroencephalography and Clinical Neurophysiology/Evoked Potentials Section. 96(2). 194–196. 37 indexed citations
14.
Ansseau, Marc, et al.. (1994). Relationship between alpha2-adrenergic function and suicidal behavior in depressed patients. Psychiatry Research. 52(2). 115–123. 13 indexed citations
15.
Hansenne, Michel, et al.. (1993). L'état de stress post-traumatique chez les brûlés : Une revue.. 1 indexed citations
16.
Ansseau, Marc, William Pitchot, A. González Moreno, J. Wauthy, & Patrick Papart. (1993). Pilot study of flesinoxan, a 5‐HT1A agonist, in major depression: Effects on sleep REM latency and body temperature. Human Psychopharmacology Clinical and Experimental. 8(4). 279–283. 18 indexed citations
17.
Ansseau, Marc, et al.. (1992). Dopaminergic function in panic disorder: Comparison with major and minor depression. Biological Psychiatry. 32(11). 1004–1011. 43 indexed citations
18.
Ansseau, M., et al.. (1992). NEUROENDOCRINE RESPONSES TO INTRAVENOUS FLESINOXAN AS AN INDEX OF SEROTONERGIC NEUROTRANSMISSION. Clinical Neuropharmacology. 15. 114B–114B. 4 indexed citations
19.
Pitchot, William, Michel Hansenne, A. González Moreno, & Marc Ansseau. (1992). Suicidal behavior and growth hormone response to apomorphine test. Biological Psychiatry. 31(12). 1213–1219. 34 indexed citations
20.
Pitchot, William, A. González Moreno, M. Ansseau, & R. von Frenckell. (1992). GROWTH HORMONE RESPONSE TO APOMORPHINE TEST IN RETARDED VS AGITATED DEPRESSED PATIENTS. Clinical Neuropharmacology. 15. 284B–284B. 1 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by I. Másala Breakdown of academic impact, for papers by M. Stamenković Breakdown of academic impact, for papers by Elisa Lorch Breakdown of academic impact, for papers by Kunihiko Shioe Breakdown of academic impact, for papers by Stephen Morris Breakdown of academic impact, for papers by Caitlin E. Carey Breakdown of academic impact, for papers by Joan Massana Breakdown of academic impact, for papers by Rebecca Rhodes Breakdown of academic impact, for papers by Elen Russell Breakdown of academic impact, for papers by Dubravka Jancic
Rankless by CCL
2026